Skip to main content

Articles

Page 63 of 335

  1. Tyrosine kinase inhibitors (TKIs) as first-line therapy for Chronic Myeloid Leukemia (CML) show a high success rate. However, a low number of patients with long-term treatment-free remission (TFR) were observe...

    Authors: Aliza Mohd Yacob, Nor Asiah Muhamad, Kian Meng Chang, Hamidah Akmal Hisham, Yuslina Mat Yusoff and Latifah Ibrahim
    Citation: BMC Cancer 2022 22:332
  2. We aimed to evaluate the prognosis and adjuvant chemotherapy (ACT) in intrahepatic cholangiocarcinoma (ICC) patients with different etiology after radical resection.

    Authors: Qi Li, Chen Chen, Jingbo Su, Yinghe Qiu, Hong Wu, Tianqiang Song, Xianhai Mao, Yu He, Zhangjun Cheng, Jingdong Li, Wenlong Zhai, Dong Zhang, Zhimin Geng and Zhaohui Tang
    Citation: BMC Cancer 2022 22:329
  3. This study aimed to compare the survival outcomes between squamous cell carcinoma (SCC) and adenocarcinoma/adenosquamous carcinoma (AC/ASC) of the cervix after radical radiotherapy and chemotherapy.

    Authors: Ping Liu, Mei Ji, Yanxiang Kong, Zhifeng Huo, Qiubo Lv, Qinghuang Xie, Danbo Wang, Biliang Chen, Hailin Wang, Zhumei Cui, Qianqing Wang, Xiaonong Bin, Jinghe Lang and Chunlin Chen
    Citation: BMC Cancer 2022 22:326
  4. Endometrial cancer (EC) is the most frequent malignancy of the female genital tract worldwide. Our study aimed to construct an effective protein prognostic signature to predict prognosis and immunotherapy resp...

    Authors: Jinzhi Lai, Tianwen Xu and Hainan Yang
    Citation: BMC Cancer 2022 22:325

    The Correction to this article has been published in BMC Cancer 2022 22:480

  5. This article has been retracted. Please see the Retraction Notice for more detail: https://​doi.​org/​10.​1186/​1471-2407-14-243.

    Authors: Damao Huang, Yuejin Li, Na Liu, Zhenlin Zhang, Zhengke Peng, Chaojun Duan, Xiaowei Tang, Gongjun Tan, Guangrong Yan and Faqing Tang
    Citation: BMC Cancer 2022 22:324
  6. The prognosis of patients with NSCLC harboring oncogenic driver gene alterations, such as EGFR gene mutations or ALK fusion, has improved dramatically with the advent of corresponding molecularly targeted drugs. ...

    Authors: Shoko Sonobe Shimamura, Takehito Shukuya, Tetsuhiko Asao, Daisuke Hayakawa, Kana Kurokawa, Shiting Xu, Keita Miura, Yoichiro Mitsuishi, Ken Tajima, Rina Shibayama, Naoko Shimada, Fumiyuki Takahashi and Kazuhisa Takahashi
    Citation: BMC Cancer 2022 22:323
  7. The BIRC5 gene encodes for the Survivin protein, which is a member of the inhibitor of apoptosis family. Survivin is found in humans during fetal development, but generally not in adult cells thereafter. Previous...

    Authors: Anna Fäldt Beding, Peter Larsson, Khalil Helou, Zakaria Einbeigi and Toshima Z. Parris
    Citation: BMC Cancer 2022 22:322
  8. Pulmonary neuroendocrine neoplasms can be divided into typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma, and small cell (lung) carcinoma. According to the World Health Organization, t...

    Authors: Ying Zhang, Weiya Wang, Qianrong Hu, Zuoyu Liang, Ping Zhou, Yuan Tang and Lili Jiang
    Citation: BMC Cancer 2022 22:321
  9. Targeted therapies for Primary liver cancer (HCC) is limited to the multi-kinase inhibitors, and not fully effective due to the resistance to these agents because of the heterogeneous molecular nature of HCC d...

    Authors: Kubra Narci, Deniz Cansen Kahraman, Altay Koyas, Tulin Ersahin, Nurcan Tuncbag and Rengul Cetin Atalay
    Citation: BMC Cancer 2022 22:320
  10. Some patients diagnosed with cancer use medical cannabis to self-manage undesirable symptoms, including nausea and pain. To improve patient safety and oncological care quality, the routes of administration for...

    Authors: Billy Vinette, José Côté, Ali El-Akhras, Hazar Mrad, Gabrielle Chicoine and Karine Bilodeau
    Citation: BMC Cancer 2022 22:319
  11. To date, Siewert type II adenocarcinoma of the esophagogastric junction (ST-II AEG) can be removed radically utilizing either the abdominal-transhiatal (TH) or the right thoracoabdominal (RTA) approaches. Beca...

    Authors: Qiying Song, Xiongguang Li, Di Wu, Shuo Li, Tianyu Xie, Yixun Lu, Liyu Zhang, Ziyao Xu, Lu Liu, Xin Guo and Xinxin Wang
    Citation: BMC Cancer 2022 22:318
  12. Investigating dynamic changes in blood-parameters and weight in patients with locally advanced non-small cell lung cancer (NSCLC) receiving durvalumab maintenance therapy after chemoradiotherapy (cCRT). Labora...

    Authors: J. Guggenberger, S. Kenndoff, J. Taugner, L. Käsmann, B. Flörsch, C. Belka, C. Eze and F. Manapov
    Citation: BMC Cancer 2022 22:317
  13. N6-methyladenosine (m6A) modification and long non-coding RNAs (lncRNAs) play pivotal roles in gastric cancer (GC) progression. The emergence of immunotherapy in GC has created a paradigm shift in the approach...

    Authors: Yi Wang, Gui-Qi Zhu, Di Tian, Chang-Wu Zhou, Na Li, Ying Feng and Meng-Su Zeng
    Citation: BMC Cancer 2022 22:316
  14. Colorectal adenoma (CA) is an important precancerous lesion and early screening target of colorectal cancer (CRC). Lipids with numerous physiological functions are proved to be involved in the development of C...

    Authors: Hailin Zhou, Yanying Nong, Yifan Zhu, Yunxiao Liang, Jiahao Zhang, Hongwei Chen, Pingchuan Zhu and Qisong Zhang
    Citation: BMC Cancer 2022 22:314
  15. Bladder cancer (BC) is one of the most common malignant tumors of the urinary system, and cisplatin (CDDP) is a critical chemical drug for the treatment of BC. However, CDDP-resistance seriously limits the the...

    Authors: Ming Sun, Xuefeng Liu, Wenyan Zhao, Bin Zhang and Peng Deng
    Citation: BMC Cancer 2022 22:313
  16. Management of bladder cancer (BLCA) has not changed significantly in the past few decades, with platinum agent chemotherapy being used in most cases. Chemotherapy reduces tumor recurrence after resection, but ...

    Authors: Sayani Bhattacharjee, Matthew J. Sullivan, Rebecca R. Wynn, Alex Demagall, Andrew S. Hendrix, Puneet Sindhwani, Firas G. Petros and Nagalakshmi Nadiminty
    Citation: BMC Cancer 2022 22:312
  17. Immunotherapy has become a new therapy for advanced hepatocellular carcinoma (HCC); however, its treatment results are considerably different. CD4+ T cells (CD4+) are the key to immunotherapy, but patients wit...

    Authors: Yong Zhao, Ling Xiang Kong, Feng Shi Feng, Jiayin Yang and Guo Wei
    Citation: BMC Cancer 2022 22:311
  18. Olanzapine has been reported to be an effective antiemetic in patients receiving carboplatin-based chemotherapy. However, the efficacy of a neurokinin-1 receptor antagonist (NK1RA) added to olanzapine, a 5-hydrox...

    Authors: Senri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, Hitoshi Kawazoe, Kazuki Tanaka, Yukiyoshi Fujita, Masakazu Abe, Hisao Imai, Masato Karayama, Yoh Hayasaki, Chiemi Hirose, Takafumi Suda, Kazuto Nakamura, Akio Suzuki, Yasushi Ohno, Ken-ichirou Morishige…
    Citation: BMC Cancer 2022 22:310
  19. Women’s perception and knowledge of breast cancer signs, symptoms, and risk factors could be conducive to breast cancer risk management and interventions. The present study aimed to explore Iranian laywomen pe...

    Authors: E. Manouchehri, A. Taghipour, A. Ebadi, F. Homaei Shandiz and R. Latifnejad Roudsari
    Citation: BMC Cancer 2022 22:309
  20. Breast cancer screening and improving imaging techniques have led to an increase in the detection rate of early, nonpalpable breast cancers. For early breast cancer, breast conserving surgery is an effective a...

    Authors: Bianca M. den Dekker, Anke Christenhusz, Thijs van Dalen, Lisa M. Jongen, Margreet C. van der Schaaf, Anneriet E. Dassen and Ruud M. Pijnappel
    Citation: BMC Cancer 2022 22:305
  21. Second-generation androgen receptor inhibitors (ARIs) have been associated with adverse events (AEs) such as fatigue, falls, fractures, and rash in non-metastatic castration-resistant prostate cancer (nmCRPC) ...

    Authors: Arif Hussain, Shan Jiang, Della Varghese, Sreevalsa Appukkuttan, Nehemiah Kebede, Kajan Gnanasakthy, Cynthia Macahilig, Reg Waldeck and Shelby Corman
    Citation: BMC Cancer 2022 22:304
  22. Few studies have addressed colon cancer surgery outcomes in an unselected cohort of octogenarian patients. The present study aimed to evaluate the relative survival of octogenarian patients after a major resec...

    Authors: Øystein Høydahl, Tom-Harald Edna, Athanasios Xanthoulis, Stian Lydersen and Birger Henning Endreseth
    Citation: BMC Cancer 2022 22:302
  23. The optimal radiation dose for treating non-metastatic superficial esophageal squamous cell carcinoma is unknown. In this retrospective observational study, we investigated the influence of radiation dose and ...

    Authors: Toshiki Ikawa, Ryu Ishihara, Katsunori Matsueda, Koji Konishi, Sachiko Yamamoto, Masahiro Morimoto, Naoyuki Kanayama and Teruki Teshima
    Citation: BMC Cancer 2022 22:301
  24. Well-differentiated and dedifferentiated liposarcomas are rare soft tissue tumors originating in adipose tissue that share genetic abnormalities but have significantly different metastatic potential. Dediffere...

    Authors: Thanh N. Dang, Rafael P. Tiongco, Loren M. Brown, Jessica L. Taylor, John M. Lyons, Frank H. Lau and Z. Elizabeth Floyd
    Citation: BMC Cancer 2022 22:300
  25. Lung cancer is the most common malignant tumor, and it has a high mortality rate. However, the study of miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer (NSCLC) is insuf...

    Authors: Wei Zhang, Qian Zhang, Li Che, Zhefan Xie, Xingdong Cai, Ling Gong, Zhu Li, Daishun Liu and Shengming Liu
    Citation: BMC Cancer 2022 22:299
  26. ITPR1 is a key gene for autophagy, but its biological function is still unclear, and there are few studies on the correlation between ITPR1 gene expression and the occurrence and development of breast cancer.

    Authors: Bing Han, Fang Zhen, Xiu-Shuang Zheng, Jing Hu and Xue-Song Chen
    Citation: BMC Cancer 2022 22:297
  27. The incidence of human papillomavirus (HPV) positive oropharyngeal cancer (OPC) is rising but HPV negative OPC is decreasing in Western countries. In Taiwan, the incidence of HPV negative OPC is common but the...

    Authors: Cheng-Ping Wang, Tseng-Cheng Chen, Wan-Lun Hsu, Jenn-Ren Hsiao, Peir-Rong Chen, Mu-Kuan Chen, Chun-Hung Hua, Ming-Hsui Tsai, Jenq-Yuh Ko, Pei-Jen Lou, Chun-Ju Chiang, Chen-Tu Wu and Yih-Leong Chang
    Citation: BMC Cancer 2022 22:296
  28. Breast cancer (BC) is the most common cancer among women. Studies have shown that cancer patients can develop depression impacting their quality of life, treatment outcomes, and survival rates. This study aime...

    Authors: Dana Sadaqa, Ahlam Farraj, Hani Naseef, Hamza Alsaid, Nimeh Al-Shami and Abdallah Damin AbuKhalil
    Citation: BMC Cancer 2022 22:295
  29. Dacomitinib is a second-generation, irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). ARCHER-1050 showed that this agent can improve progression-free survival and overall surv...

    Authors: Bo Zhang, Chunlei Shi, Zhiqiang Gao, Hua Zhong, Liwen Xiong, Aiqin Gu, Weimin Wang, Tianqing Chu, Wei Zhang, Huimin Wang, Xueyan Zhang, Runbo Zhong and Baohui Han
    Citation: BMC Cancer 2022 22:294
  30. This study aimed to evaluate the efficiency and prognostic factors of lenvatinib plus programmed death 1 (PD-1) blockades in patients with advanced hepatocellular carcinoma (HCC), especially for those with tum...

    Authors: Xuqi Sun, Qi Zhang, Jie Mei, Ziliang Yang, Minshan Chen and Tingbo Liang
    Citation: BMC Cancer 2022 22:293
  31. Detection of the ROS1 rearrangement is mandatory in patients with advanced or metastatic non-small cell lung cancer (NSCLC) to allow targeted therapy with specific inhibitors. However, in Spanish clinical practic...

    Authors: Federico Rojo, Esther Conde, Héctor Torres, Luis Cabezón-Gutiérrez, Dolores Bautista, Inmaculada Ramos, David Carcedo, Natalia Arrabal, J. Francisco García, Raquel Galán and Ernest Nadal
    Citation: BMC Cancer 2022 22:292
  32. Traumatic brain injury (TBI) has been reported as a risk factor for brain cancer development. However, the magnitude of the impact of TBI on systemic cancer development has not been clarified.

    Authors: Chung-Che Lu, Tee-Tau Eric Nyam, Chung-Han Ho, Jinn-Rung Kuo, Chung-Ching Chio, Jhi-Joung Wang and Che-Chuan Wang
    Citation: BMC Cancer 2022 22:291
  33. Colorectal cancer (CRC) is the third most prevalent cancer in the world, which remains one of the leading causes of cancer-related deaths. Accurate prognosis prediction of CRC is pivotal to reduce the mortalit...

    Authors: Yiding Li, Guiling Wu, Yujie Zhang, Ben Han, Wanli Yang, Xiaoqian Wang, Lili Duan, Liaoran Niu, Junfeng Chen, Wei Zhou, Jinqiang Liu, Daiming Fan and Liu Hong
    Citation: BMC Cancer 2022 22:290
  34. Pheochromocytomas (PCC) and paragangliomas (PGL) are catecholamine-producing neuroendocrine tumors. According to the World Health Organization Classification 2017, all PCC/PGL are considered to have malignant ...

    Authors: Takao Kamai, Satoshi Murakami, Kyoko Arai, Daisaku Nishihara, Toshitaka Uematsu, Kazuyuki Ishida and Toshiki Kijima
    Citation: BMC Cancer 2022 22:289
  35. Osteosarcoma (OS) is one of the most common primary bone malignant tumors. Osteoclasts have been shown to have a valuable role in OS. In the present study, we analyzed the differentiation states of osteoclasts...

    Authors: Haiyu Shao, Meng Ge, Jun Zhang, Tingxiao Zhao and Shuijun Zhang
    Citation: BMC Cancer 2022 22:288
  36. Long-term antiviral treatments are associated with a significantly lower hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients by reducing HBV DNA concentrations. However, it is still ...

    Authors: Ze-Hong Huang, Gui-Yang Lu, Ling-Xian Qiu, Guo-Hua Zhong, Yue Huang, Xing-Mei Yao, Xiao-Hui Liu, Shou-Jie Huang, Ting Wu, Quan Yuan, Ying-Bin Wang, Ying-Ying Su, Jun Zhang and Ning-Shao Xia
    Citation: BMC Cancer 2022 22:287
  37. MDT discussion is the gold standard for cancer care in the UK. With the incidence of cancer on the rise, demand for MDT discussion is increasing. The need for efficiency, whilst maintaining high standards, is ...

    Authors: George T. F. Brown, Hilary L. Bekker and Alastair L. Young
    Citation: BMC Cancer 2022 22:286
  38. Response guided treatment in breast cancer is highly desirable, but the effectiveness is only established based on residual cellularity from histopathological analysis after surgery. Tubule formation, a key co...

    Authors: Kwok-Shing Chan, Sai Man Cheung, Nicholas Senn, Ehab Husain, Yazan Masannat, Steven Heys and Jiabao He
    Citation: BMC Cancer 2022 22:285
  39. It has been reported that Osaka prognostic score (OPS), based on C-reactive protein (CRP), total lymphocyte counts (TLC) and albumin (ALB), was relevant to prognosis in colorectal cancer. However, the role of ...

    Authors: Jifeng Feng, Lifen Wang, Liang Wang, Xun Yang and Guangyuan Lou
    Citation: BMC Cancer 2022 22:284
  40. Prostate cancer is the most common internal malignancy in Australian men, and although most patients have good survival outcomes, treatment toxicities can impair function, leading to diminished quality of life...

    Authors: Kendrick Koo, Nathan Papa, Melanie Evans, Michael Jefford, Maarten IJzerman, Victoria White, Sue M. Evans, Eli Ristevski, Jon Emery and Jeremy Millar
    Citation: BMC Cancer 2022 22:283
  41. Although targeting of the cholesterol pathway by statins prevents breast cancer development in mouse models, efficacy is not absolute. Therefore, the goal of this study is to investigate if the upregulation in...

    Authors: Anjana Bhardwaj, Matthew D. Embury, Zhenlin Ju, Jing Wang and Isabelle Bedrosian
    Citation: BMC Cancer 2022 22:282
  42. In cancer survival analyses using population-based data, researchers face the challenge of ascertaining the timing of recurrence. We previously developed algorithms to identify recurrence of breast cancer. Thi...

    Authors: Hyunmin Jung, Mingshan Lu, May Lynn Quan, Winson Y. Cheung, Shiying Kong, Sasha Lupichuk, Yuanchao Feng and Yuan Xu
    Citation: BMC Cancer 2022 22:281
  43. Gastric cancer (GC) is one of the most common malignancies, and the liver is the most common site of hematogenous metastasis of GC. AMIGO2 is a type I transmembrane protein that has been implicated in tumour c...

    Authors: Keisuke Goto, Masaki Morimoto, Mitsuhiko Osaki, Akimitsu Tanio, Runa Izutsu, Yoshiyuki Fujiwara and Futoshi Okada
    Citation: BMC Cancer 2022 22:280

Featured videos

View featured videos from across the BMC-series journals